← Open Payments lookup

ERICA GIORDANO: Open Payments

NPI 1124653399 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,112 in 98 payments from 17 companies in 2025. Trend: 2023 $1,935 · 2024 $1,677 · 2025 $2,112

Food & beverage: $2,112
CompanyPaymentsAmount
ABBVIE INC.21$432
Salix Pharmaceuticals, a division of Bausch Health US, LLC17$337
Madrigal Pharmaceuticals7$205
GENZYME CORPORATION7$199
Janssen Biotech, Inc.9$183
Gilead Sciences, Inc.7$145
Celltrion USA Inc.6$136
Lilly USA, LLC6$131
PFIZER INC.5$79
Ardelyx, Inc.3$67

Products named: XIFAXAN, DUPIXENT, REZDIFFRA, RINVOQ, TREMFYA, VEGZELMA, OMVOH, IBSRELA.

Industry payments across TX — which companies pay providers there.